Skip to main content
Clinical Trials/NCT01238484
NCT01238484
Terminated
Not Applicable

Ankle Equinus Contracture Treated With Dynamic Splinting in a Randomized, Controlled Trial

Dynasplint Systems, Inc.2 sites in 1 country15 target enrollmentAugust 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ankle Equinus
Sponsor
Dynasplint Systems, Inc.
Enrollment
15
Locations
2
Primary Endpoint
Range of Motion
Status
Terminated
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to determine if the Ankle Dorsiflexion Dynasplint System (DS) is effective in treating contracture for patients with Ankle Equinus secondary to diabetes mellitus.

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
January 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Previous Diagnosis Diabetes Mellitus
  • Reduced flexibility in AROM of extension in the ankle
  • Less than 10º Maximal, Active Dorsiflexion, while upright
  • Impaired gait pattern

Exclusion Criteria

  • Previous surgical treatment for this pathology
  • Previous surgery of the Achilles tendon or triceps surae
  • Current treatment with corticosteroids
  • Current treatment with Botulinium Toxin-A (Botox), lower extremity
  • Current treatment Fluoroquinolones (antibiotic medication)
  • Current use of muscle relaxant medications
  • Fibromyalgia
  • Stroke, CVA, Brain Injury, Spinal Cord Injury, or any neural pathology causing plasticity or hypertonicity
  • Current participation in manual, physical therapy
  • Treatment with electrical stimulation assisting ambulation (i.e. Bioness, WalkAide, Parastep, etc.)

Outcomes

Primary Outcomes

Range of Motion

Time Frame: 4 months

The primary outcome is change in ankle range of motion

Secondary Outcomes

  • Pain(4 months)

Study Sites (2)

Loading locations...

Similar Trials